AntriaBio

Investors

Press Releases

Jul 25, 2017 AntriaBio Announces First Patient Dosed in Phase 1 Clinical Study of AB101
Jul 17, 2017 AntriaBio Announces $13 Million Close of Private Placement Transaction and Plan to Dose First Patient with AB101 This Month
Jun 5, 2017 AntriaBio Files Investigational New Drug Application for Once-Weekly Basal Insulin AB101
May 1, 2017 AntriaBio Formally Engages CRO for the Conduct of its Phase I First-in-Human Clinical Trial of AB101
Mar 22, 2017 AntriaBio Appoints Two Pharmaceutical Executives to its Board of Directors
Dec 15, 2016 AntriaBio Announces Offer to Amend Warrants to Purchase Shares of Common Stock
Sep 22, 2016 AntriaBio Announces Formation of Subsidiary and Plan to Raise Capital in South Korea
Jun 29, 2016 AntriaBio Announces $12 Million Private Placement
Jun 22, 2016 AntriaBio Announces Preclinical Proof of Concept for Once-Weekly Basal Insulin AB101 in Diabetic Miniature Swine
Jan 6, 2016 AntriaBio Announces Appointment of Michael Deperro as Vice President of Operations

<< Previous
1
2
3
4
5
6
7
Next >>

Show All